Efficacy and safety of oral decitabine/cedazuridine (astx727) in the cmml subpopulation from phase 2 and ascertain phase 3 studies
LEUKEMIA RESEARCH(2023)
Key words
MDS, oral decitabine/cedazuridine, oral, hypomethylating agent, CMML, phase II, phase III
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined